Pharmacological characterization of the human ionotropic glutamate receptor subtype GluR3 stably expressed in mammalian cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 1, 1998, Pages 358-370

  Varney, M A ^a   Rao, S P ^a   Jachec, C ^a   Deal, C ^a   Hess, S D ^a   Daggett, L P ^a   Lin, F F ^a   Johnson, E C ^a   Velicelebi G ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTAMATE RECEPTOR; IONOTROPIC RECEPTOR; RECEPTOR SUBTYPE;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CALCIUM CELL LEVEL; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR CLONING; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; STRUCTURE ANALYSIS;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BENZOTHIADIAZINES; BINDING, COMPETITIVE; BRAIN; CELLS, CULTURED; DIURETICS; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; HUMANS; KIDNEY; QUINOXALINES; RATS; RECEPTORS, AMPA; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0031979510     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Andersen PH, Tygesen CK, Rasmussen JS, Søegaard-Nielsen L, Hansen A, Hansen K. Kiemer A and Stidsen CE (1996) Stable expression of homomeric AMPA-selective glutamate receptors in BHK cells. Eur J Pharmacol 311:95-100.
2. Arvola M and Keinanen K (1996) Characterization of the ligand-binding domains of glutamate receptor (GluR)-B and GluR-D subunits expressed in Escherichia coli as perisplasmic proteins. J Biol Chem 271:15527-15532.
3. Bennett JA and Dingledine R (1995) Topology profile for a glutamate receptor: Three transmembrane domains and a channel-lining reentrant membrane loop. Neuron 14:373-384.
4. Berjukow S, Döring F, Froschmayr M, Grabner M, Glossmann H and Hering S (1996) Endogenous calcium channels in human embryonic kidney (HEK293) cells. Br J Pharmacol 118:748-754.
5. Bettler B and Mulle C (1995) AMPA and kainate receptors. Neuropharmacology 34:123-139.
6. Blackstone CD, Moss SJ, Martin LJ, Levey AL, Price DL and Huganir RL (1992) Biochemical characterization and localization of a non-N-Methyl-D-Aspartate glutamate receptor in rat brain. J Neurochem 58:1118-1126.
7. Boulter J, Hollmann M, O'Shea-Greenfield A, Hartley M, Deneris E, Maron C and Heinemann S (1990) Molecular cloning and functional expression of glutamate receptor subunit genes, Science 249:1033-1037.
8. A receptor and compromises the modulatory interactions. Eur J Pharmacol 173:65-73.
9. Burnashev N, Monyer H, Seeburg PH and Sakmann B (1992) Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 8:189-198.
10. Burnashev N, Zhou Z, Neher E and Sakmann B (1995) Fractional calcium currents through recombinant GluR channels of the NMDA, AMPA and kainate receptor subtypes. J Physiol (Lond) 485:403-418.
11. Cha J-H, Makowiec RL, Penney JB and Young AB (1992) Multiple states of rat brain (R.S.)-α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptors as revealed by quantitative autoradiography. Mol Pharmacol 41:832-838.
12. Chazot PL, Cik M and Stephenson FA (1992) Immunological detection of the NMDAR1 glutamate receptor subunit expressed in human embryonic kidney 293 cells and in rat brain. J Neurochem 59:1176-1178.
13. Condorelli DF, Belluardo N, Mudò G, Dell'Albani P, Jiang X and Giuffrida-Stella AM (1994) Changes in gene expression of AMPA-selective glutamate receptor subunits induced by status epilepticus in rat brain. Neurochem Int 25:367-376.
14. Daggett LP, Sacaan AI, Akong M, Rao SP, Hess SD, Liaw C, Urrutia A, Jachce C, Ellis SB, Dreessen J, Knöpfel T, Landwehrmeyer GB, Testa CM, Yöung AB, Varney M, Johnson EC and Veliçelebi G (1995) Molecular and functional characterization of recombinant-human metabotropic glutamate receptor subtype 5. Neuropharmacology 34:871-886.
15. Davies J and Watkins JC (1985) Depressant actions of γ-D-glutamylaminomethyl sulphonate (GAMS) on amino acid-induced and synaptic excitation in the cat spinal cord. Brain Res 327:113-120.
16. Donevan SD and Rogawski MA (1993) GYK1 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 10:51-59.
17. 2 subunits of a DHP-sensitive calcium channel. Science 241:1661-1664.
18. Fletcher EJ and Lodge D (1996) New developments in the molecular pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate receptors. Pharmacol Ther 70:65-89.
19. 3H]-alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (AMPA) to rat cortex membranes reveals two sites or affinity states. J Recept Res 11:727-741.
20. 2+ permeability of AMPA receptors in principle neurons and interneurons in rat CNS, Neuron 15:193-204.
21. Gill R (1994) The pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia. Cerebrovasc Brain Metab Rev 6:225-256.
22. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
23. Hall JM, Caulfield MP, Watson SP and Guard S (1994) Receptor subtypes or species homologues: Relevance to drug discovery. Trends Pharmacol Sci 14:376-383.
24. 3H]-AMPA binding to rat brain membranes: Evidence that AMPA receptor desensitization increases agonist affinity. Brain Res 628:345-348.
25. 3H]AMPA to rat brain synaptic membranes: Effects of a series of structural analogues of the non-NMDA receptor agonist willardiine. Neuropharmacology 34:405-410.
26. 3H]-5-fluorowillardiine binding in rat brain, Br J Pharmacol 116:2033-2039.
27. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252: 851-853.
28. Hollmann M, Maron C and Heinemann S (1994) N-glycosylation site tagging suggests a three transmembrane domain topology for the glutamate receptor GluR1. Neuron 13:1331-1343.
29. Honoré T and Drejer J (1988) Chaotropic ions affect the conformation of quisqualate receptors in rat cortical membranes. J Neurochem 51:457-461.
30. Honoré T, Davies SN, Drejer J, Fletcher EJ, Jacobsen P, Lodge D and Nielsen FE (1988) Quinoxalinediones: potent competitive non-NMDA glutamate antagonists. Science 241:701-703.
31. 3H]AMPA, a structural analogue of glutamic acid, to rat brain membranes. J Neurochem 38:173-178.
32. 3H-CNQX binds with equal affinity to two agonist states of quisqualate receptors. Biochem Pharmacol 38:3207-3212.
33. 2+ in cultured neurons from rat brain. J Neurochem 64:2049-2056.
34. Hullebroeck MF and Hampson DR (1992) Characterization of the oligosaccharide side chains on kainate binding proteins and AMPA receptors. Brain Res 590:187-192.
35. Hunter C and Wenthold RJ (1992) Solubilization and purification of an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding protein from bovine brain. J Neurochem 58:1379-1385.
36. Johansen TH, Chaudhary A and Verdoorn TA (1995) Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors. Mol Pharmacol 48:946-955.
37. Kawamoto S, Hattori S, Sakimura K, Mishina M and Okuda K (1995) N-linked glycosylation of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)-selective glutamate receptor channel alpha 2 subunit is essential for the acquisition of ligand-binding activity. J Neurochem 64:1258-1266.
38. Keinänen K, Wisden W, Sommer B, Werner P, Herb A, Verdoorn TA, Sakmann B and Seeburg P (1990) A family of AMPA-selective glutamate receptors. Science 249:556-560.
39. Kessler M, Arai A, Quan A and Lynch G (1996) Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: Lack of competition between cyclothiazide and GYKI 52466. Mol Pharmacol 49:123-131.
40. Kingston RE (1996) Calcium phosphate transfections, in Current Protocols in Molecular Biology (Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K, eds) pp 9.1.4-9.1.6, John Wiley & Sons, New York, NY.
41. Leff P and Dougall IG (1993) Further concerns over Cheng-Prusoff analysis. Trends Pharmacol Sci 14:110-112.
42. Lomeli H, Mosebacher J, Melcher T, Hoger T, Geiger JRP, Kuner T, Monyer H, Higuchi M, Bach A and Seeburg PH (1994) Controlof kinetic properties of AMPA receptor channels by nuclear RNA editing. Science 266:1709-1713.
43. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
44. McNamara JO, Eubanks JH, McPherson JD, Wasmuth JJ, Evans GA and Heinemann SF (1992) Chromosomal localization of human glutamate receptors. J Neurosci 12:2555-2562.
45. Mosbacher J, Schoepfer R, Monyer H, Burnashev N, Seeburg PH, Ruppersberg JP (1994) A molecular determinant for submillisecond desensitization in glutamate receptors. Science 266:1059-1062.
46. 3H]α-Amino-Hydroxy-5-Methylisoxazole-4-Propionic Acid (AMPA) and a filtration assay. Neurochem Res 12:775-782.
47. Nakanishi N, Shneider NA and Axel R (1990) A family of glutamate receptor genes: Evidence for the formation of heteromultimer receptors with distinct channel properties. Neuron 5:569-581.
48. Neher E and Augustine GJ (1992) Calcium gradients and buffers in bovine chromaffin cells. J Physiol (Lond) 450:273-301.
49. 3H]α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sites. J Neurochem 54:686-695.
50. 3H]NS 257, a novel competitive AMPA receptor antagonist, to rat brain membranes and brain sections. J Neurochem 65:1264-1273.
51. Okada M, Kohara A and Yamaguchi T (1996) Characterization of YM90K, a selective and potent antagonist of AMPA receptors, in rat cortical mRNA-injected Xenopus oocytes. Eur J Pharmacol 309:299-306.
52. Palmer AJ and Lodge D (1993) Cydothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655. Eur J Pharmacol Mol Pharmacol 244:193-194.
53. Partin KM, Patneau DK and Mayer ML (1994) Cydothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants. Mol Pharmacol 46:129-138.
54. Partin KM and Mayer ML (1996) Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655. Mol Pharmacol 49:142-148.
55. Partin KM, Fleck MW and Mayer ML (1996) AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by Cyclothiazide, aniracetam, and thiocyanate. J Neurosci 16:6634-6647.
56. Patneau DK, Mayer ML, Jane DE and Watkins JC (1992) Activation and desensitization of AMPA/kainate receptors by novel derivatives of willardiine. J Neurosci 12:595-606.
57. Patneau DK, Vyklicky L Jr and Mayer ML (1993) Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate. J Neurosci 13: 3496-3509.
58. Puckett C, Gomez CM, Korenberg JR, Tung H, Meier TJ, Chen XN and Hood L (1991) Molecular cloning and chromosomal localization of one of the human glutamate receptor genes. Proc Natl Acad Sci USA 88:7557-7561.
59. Rammes G, Swandulla D, Collingridge GL, Hartmann S and Parsons CG (1996) Interactions of 2,3-benzodiazepines and Cydothiazide at AMPA receptors: Patch clamp recordings in cultured neurones and area CA1 in hippocampal slices. Br J Pharmacol 117:1209-1221.
60. Rampersad V, Elliott CE, Nutt SL, Foldes RL and Kamboj RK (1994) Human glutamate receptor hGluR3 flip and flop isoforms: Cloning and sequencing of the cDNAs and primary structure of the proteins. Biochim Biophys Acta 1219:563-566.
61. Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B, Hughes TE, Heinemann SF and McNamara JO (1994) Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265:648-651.
62. Romano C and Goldstein G (1980) Stereospecific nicotine receptors on rat brain membranes. Science 210:647-650.
63. Sheng M, Cummmgs J, Roldan LA, Jan YN and Jan LY (1994) Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368:144-147.
64. Sommer B, Keinanen K, Verdoorn TA, Wisden W, Burnashev N, Herb A. Kohler M, Takagi T, Sakmann B and Seeburg PH (1990) Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 249:1580-1585.
65. Sommer B, Kohler M, Sprengel R and Seeburg PH (1991) RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67:11-19
66. Stern-Bach Y, Bettler B, Hartley M, Sheppard PO, O'Hara PJ and Heinemann SF (1994) Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino acid-binding proteins. Neuron 13:1345-1357.
67. Sun W, Ferrer Montiel AV and Montai M (1994) Primary structure and functional expression of the AMPA/kainate receptor subunit 2 from human brain. Neuroreport 5:441-444.
68. Swanson GT, Kamboj SK and Cull-Candy S (1997) Single-channel properties of recombinant AMPA receptors depend on RNA editing, splice variation, and subunit composition. J Neurosci 17:58-69.
69. Twyman RE, Gahring LC, Spiess J and Rogers SW (1995) Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 14:755-762.
70. Varney MA, Jachec C, Deal C, Hess SD, Daggett LP, Skvoretz R, Urcan M, Morrison J, Moran T, Johnson EC and Veliçelebi G (1996) Stable expression and characterization of recombinant human heteromeric NMDA receptor subtypes NMDAR1A/2A and NMDAR1A/2B in mammalian cells. J Pharmacol Exp Ther 279:367-378.
71. Verdoorn TA, Johansen TH, Drejer J and Nielsen EO (1994) Selective block of recombinant GluR6 receptors by NS-102, a novel non-NMDA receptor antagonist. Eur J Pharmacol 269:43-49.
72. Wahl P, Nielsen B, Krogsgaard-Larsen P, Hansen JJ, Schousboe A and Miledi R (1992) Stereoselective effects of AMOA on non-NMDA receptors expressed in Xenopus oocytes. J Neurosci Res 33:392-397.
73. Yamada KA and Tang CM (1993) Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J Neurosci 13: 3904-3915.
74. Zorumski CF, Yamada KA, Price MT and Olney JW (1993) A benzodiazepine recognition site associated with the non-NMDA glutamate receptor. Neuron 10:61-67.